blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3529250

EP3529250 - IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES AND PYRAZOLOPYRIDINONES AS PDE1 INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.10.2024
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  03.11.2023
FormerGrant of patent is intended
Status updated on  09.05.2023
FormerExamination is in progress
Status updated on  18.02.2022
FormerRequest for examination was made
Status updated on  26.07.2019
FormerThe international publication has been made
Status updated on  28.04.2018
Formerunknown
Status updated on  07.11.2017
Most recent event   Tooltip01.11.2024Lapse of the patent in a contracting state
New state(s): SI		published on 04.12.2024 [2024/49]
Applicant(s)For all designated states
H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
[2019/35]
Inventor(s)01 / KEHLER, Jan
c/o H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
02 / RASMUSSEN, Lars, Kyhn
c/o H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
03 / LANGGÅRD, Morten
c/o H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
04 / JESSING, Mikkel
c/o H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
05 / VITAL, Paulo, Jorge, Vieira
c/o H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
06 / JUHL, Karsten
c/o H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
 [2019/35]
Representative(s)H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
[2019/35]
Application number, filing date17791007.217.10.2017
[2019/35]
WO2017EP76481
Priority number, dateDK2016PA0064318.10.2016         Original published format: DK PA201600643
DK2017PA0019114.03.2017         Original published format: DK PA201700191
[2019/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018073251
Date:26.04.2018
Language:EN
[2018/17]
Type: A1 Application with search report 
No.:EP3529250
Date:28.08.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 26.04.2018 takes the place of the publication of the European patent application.
[2019/35]
Type: B1 Patent specification 
No.:EP3529250
Date:06.12.2023
Language:EN
[2023/49]
Search report(s)International search report - published on:EP26.04.2018
ClassificationIPC:C07D471/04, C07D487/04, A61K31/437, A61K31/519, A61K31/4985, A61P25/00
[2019/35]
CPC:
C07D471/04 (EP,US); A61P25/00 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P43/00 (EP);
C07D487/04 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/35]
Extension statesBA20.05.2019
ME20.05.2019
Validation statesMA20.05.2019
TitleGerman:IMIDAZOPYRAZINONE, PYRAZOLOPYRIMIDINONE UND PYRAZOLOPYRIDINONE ALS PDE1-INHIBITOREN[2019/35]
English:IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES AND PYRAZOLOPYRIDINONES AS PDE1 INHIBITORS[2019/35]
French:IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES ET PYRAZOLOPYRIDINONES EN TANT QU'INHIBITEURS DE PDE1[2019/35]
Entry into regional phase20.05.2019National basic fee paid 
20.05.2019Designation fee(s) paid 
20.05.2019Examination fee paid 
Examination procedure20.05.2019Examination requested  [2019/35]
20.05.2019Date on which the examining division has become responsible
27.11.2019Amendment by applicant (claims and/or description)
17.02.2022Despatch of a communication from the examining division (Time limit: M06)
16.08.2022Reply to a communication from the examining division
10.05.2023Communication of intention to grant the patent
08.09.2023Fee for grant paid
08.09.2023Fee for publishing/printing paid
08.09.2023Receipt of the translation of the claim(s)
Opposition(s)09.09.2024No opposition filed within time limit [2024/46]
Fees paidRenewal fee
31.10.2019Renewal fee patent year 03
02.11.2020Renewal fee patent year 04
02.11.2021Renewal fee patent year 05
31.10.2022Renewal fee patent year 06
31.10.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.12.2023
CZ06.12.2023
DK06.12.2023
EE06.12.2023
HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
PL06.12.2023
RO06.12.2023
RS06.12.2023
SE06.12.2023
SI06.12.2023
SK06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
PT08.04.2024
[2024/49]
Former [2024/47]AT06.12.2023
CZ06.12.2023
DK06.12.2023
EE06.12.2023
HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
PL06.12.2023
RO06.12.2023
RS06.12.2023
SE06.12.2023
SK06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
PT08.04.2024
Former [2024/36]AT06.12.2023
CZ06.12.2023
EE06.12.2023
HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
PL06.12.2023
RO06.12.2023
RS06.12.2023
SE06.12.2023
SK06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
PT08.04.2024
Former [2024/35]AT06.12.2023
CZ06.12.2023
EE06.12.2023
HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
RO06.12.2023
RS06.12.2023
SE06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
Former [2024/34]EE06.12.2023
HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
Former [2024/33]HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
Former [2024/32]HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
IS06.04.2024
Former [2024/26]HR06.12.2023
LT06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
Former [2024/24]HR06.12.2023
LT06.12.2023
RS06.12.2023
SE06.12.2023
BG06.03.2024
NO06.03.2024
GR07.03.2024
Former [2024/21]LT06.12.2023
BG06.03.2024
GR07.03.2024
Former [2024/20]GR07.03.2024
Cited inInternational search[I]WO2009121919  (BOEHRINGER INGELHEIM INT [DE], et al) [I] 1-16 * page 126, line 23 - line 26 * * page 208; examples 10-11 * * page 212; example 27 * * page 215; examples 40-2 * * page 225; example 71 * * page 227; example 79 * * page 231; examples 101-102 * * page 240; examples 136-137 * * page 241; example 140 * * page 275; claim 1 *;
 [I]WO2010026214  (BOEHRINGER INGELHEIM INT [DE], et al) [I] 1-16 * page 143; examples 55-56 * * page 150; examples 72-5, 72-6 * * page 152 - page 153; examples 72-10, 72-11, 73-74 * * page 163 - page 170; examples 91-99 * * page 172 - page 174; examples 104, 106, 108 * * page 177; claim 1 * * page 191 - page 192; claim 22 *;
 [A]US2010190771  (CLAFFEY MICHELLE M [US], et al) [A] 1-16 * page 58; claim 1 *;
 [AD]WO2013053690  (LUNDBECK & CO AS H [DK]) [AD] 1-16* page 54; claim 1 *
by applicantWO2008070095
 WO2013053690
 WO2013110768
 WO2016042775
 US2016083391
 US2016083400
 WO2016055618
 WO2016147659
    - SHARRON H. FRANCIS; MITSI A. BLOUNT; JACKIE D. CORBIN, Physiol Rev, (20110000), vol. 91, pages 651 - 690
    - AMY BERNARD et al., Neuron, (20120000), vol. 73, pages 1083 - 1099
    - BLOKLAND et al., Expert Opinion on Therapeutic Patents, (20120000), vol. 22, no. 4, pages 349 - 354
    - MEDINA, A. E. FRONTIERS, Neuropharmacology, (20110200), vol. 5, page 21
    - Compendium of Organic Synthetic Methods, Wiley-Interscience, vol. I-XIII, ISSN 1934-4783
    - J. Med. Chem., (20090000), vol. 52, page 7949
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.